Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	2. Issuer Name and Ticker or Trading Symbol NATURES SUNSHINE PRODUCTS INC [ NATR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    __X__ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) BUILDING A, NO. 1289 YISHAN ROAD	3. Date of Earliest Transaction (MM/DD/YYYY) 12/11/2019
(Street) SHANGHAI, F4 200233 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, no par value per share	12/11/2019		J		14125 (1)	A	$0	14125	I	by Fosun Industrial Co., Limited (2)
Common Stock, no par value per share	12/11/2019		J		25000 (3)	A	$7.80 (4)	39125	I	by Fosun Industrial Co., Limited (2)
Common Stock, no par value per share								2854607	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:
(1)	These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of a former director of the Issuer upon the vesting of certain restricted stock units that were initially granted to the former director, as agreed between the former director and the Reporting Person.
(2)	Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person.
(3)	These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of a former director of the Issuer upon the exercise of certain stock options (the "Options") that were initially granted to the former director, as agreed between the former director and the Reporting Person.
(4)	Represents the exercise price paid by Fosun Industrial Co., Limited on behalf of the former director of the Issuer for the shares underlying the Options upon the exercise of the Options.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. BUILDING A, NO. 1289 YISHAN ROAD SHANGHAI, F4 200233		X

Signatures
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., By: /s/ Chen Qiyu/Chairman		12/13/2019
**Signature of Reporting Person		Date